Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Acquisitions & Divestments (2018 - 2019)

Apyx Medical (APYX) has disclosed Change in Acquisitions & Divestments for 2 consecutive years, with $40.9 million as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Change in Acquisitions & Divestments changed N/A year-over-year to $40.9 million, compared with a TTM value of $40.9 million through Mar 2020, down 37.68%, and an annual FY2019 reading of $80.7 million, up 213.4% over the prior year.
  • Change in Acquisitions & Divestments was $40.9 million for Q2 2019 at Apyx Medical, up from $39.8 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $40.9 million in Q2 2019 and bottomed at $25.8 million in Q4 2018.